Given the main aim of the present study is to explore the relationship between amyloid and tau pathology in AD and to determine the effects of metformin on amyloid and tau pathologies, we did not perform behavioral tests or biochemical experiments of these mice. Here, MAPT is linked to Alzheimer disease.